menu
    • menu

    Company profile for Fidia Farmaceutici Spa

    NEW Drugs in Dev: 5
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Fidia farmaceutici S.p.A. a fully integrated Italian healthcare company, part of the P&R Group, with R&D, manufacturing, marketing and sales capabilities, operates worldwide to develop and market innovative products (pharmaceuticals, medical devices and dietary supplements), mainly based on sodium hyaluronate (HY) and its derivatives. Major business areas include treatment of joint disorders, Advanced Wound Care and Dermo-aest...
    Fidia farmaceutici S.p.A. a fully integrated Italian healthcare company, part of the P&R Group, with R&D, manufacturing, marketing and sales capabilities, operates worldwide to develop and market innovative products (pharmaceuticals, medical devices and dietary supplements), mainly based on sodium hyaluronate (HY) and its derivatives. Major business areas include treatment of joint disorders, Advanced Wound Care and Dermo-aesthetics. Fidia is a world leader in HY production, using proprietary and validated extraction and fermentation processes. The Company's manufacturing operation is FDA-inspected and approved.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Fidia Farmaceutici SpaItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Via Ponte della Fabbrica 3/A - 35031 Abano Terme (PD)
    Telephone
    Telephone
    +39 049 823 2111
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.fidiapharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fidia Pharma Enters UK Market with Altacor Acquisition
    Fidia Pharma Enters UK Market with Altacor Acquisition

    03 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-03/fidia-farmaceutici-enters-the-uk-market-with-the-acquisition-of-altacor-ltd

    PHARMAWEB
    03 Sep 2025
    Share Share
    Fidia FDA Orphan Drug designation for ONCOFID®-P for malignant mesothelioma
    Fidia FDA Orphan Drug designation for ONCOFID®-P for malignant mesothelioma

    26 Jul 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/fidia-announces-the-fda-orphan-drug-designation-for-oncofid-p-for-the-treatment-of-malignant-mesothelioma-the-cancer-caused-by-exposure-to-asbestos-301338783.html

    PRNEWSWIRE
    26 Jul 2021
    Share Share
    Sanofi to sell anti-inflammatory drug portfolio to Fidia Farmaceutici
    Sanofi to sell anti-inflammatory drug portfolio to Fidia Farmaceutici

    24 Mar 2021

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/sanofi-divest-fidia-farmaceutici/

    PHARMACEUTICAL-TECHNOLOGY
    24 Mar 2021
    Share Share
    Fidia Introduces in the US the 3-injection regimen TRILURON™
    Fidia Introduces in the US the 3-injection regimen TRILURON™

    02 Dec 2019

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20191202005639/en

    BUSINESS WIRE
    02 Dec 2019
    Share Share
    Global Insomnia Market - Market Research Analysis 2015-2019
    Global Insomnia Market - Market Research Analysis 2015-2019

    05 Nov 2015

    // PR NEWSWIRE

    http://www.prnewswire.co.uk/news-releases/global-insomnia-market---market-research-analysis-2015-2019-with-eisai-merck-pfizer-sanofi--takeda-dominating-540888111.html

    PR NEWSWIRE
    05 Nov 2015
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Fidia Farmaceutici Spa and get a quotation

    Fidia Farmaceutici Spa is a supplier offers 4 products (APIs, Excipients or Intermediates).

    Find Sodium Hyaluronate bulk with CEP offered by Fidia Farmaceutici Spa

    Find Acyclovir Sodium bulk offered by Fidia Farmaceutici Spa

    Find Piretanide bulk offered by Fidia Farmaceutici Spa

    Find bulk offered by Fidia Farmaceutici Spa

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search